Wojciech Jóźwicki Selected Research

25-Hydroxyvitamin D3 1-alpha-Hydroxylase (25 Hydroxyvitamin D3 1 alpha Hydroxylase)

1/2019	On the relationship between VDR, RORα and RORγ receptors expression and HIF1-α levels in human melanomas.
1/2019	Vitamin D receptors (VDR), hydroxylases CYP27B1 and CYP24A1 and retinoid-related orphan receptors (ROR) level in human uveal tract and ocular melanoma with different melanization levels.
1/2017	Vitamin D signaling and melanoma: role of vitamin D and its receptors in melanoma progression and management.
10/2015	Expression of Vitamin D Receptor (VDR) Positively Correlates with Survival of Urothelial Bladder Cancer Patients.
2/2015	Decreased expression of CYP27B1 correlates with the increased aggressiveness of ovarian carcinomas.
10/2014	CYP24A1 expression inversely correlates with melanoma progression: clinic-pathological studies.
3/2013	Expression of the vitamin D-activating enzyme 1α-hydroxylase (CYP27B1) decreases during melanoma progression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wojciech Jóźwicki Research Topics

Disease

20	Neoplasms (Cancer) 01/2019 - 03/2010
9	Melanoma (Melanoma, Malignant) 01/2019 - 03/2013
7	Neoplasm Metastasis (Metastasis) 01/2019 - 09/2012
4	Urinary Bladder Neoplasms (Bladder Cancer) 03/2016 - 09/2014
2	Ovarian Neoplasms (Ovarian Cancer) 11/2020 - 02/2015
2	Carcinoma (Carcinomatosis) 02/2016 - 02/2015
2	Nevus (Nevi) 10/2014 - 03/2013
2	Hypersensitivity (Allergy) 01/2014 - 01/2012
2	Lymphatic Metastasis 10/2013 - 09/2012
1	Infections 01/2022
1	Papillomavirus Infections 01/2022
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022
1	Uveal melanoma 01/2019
1	Hypoxia (Hypoxemia) 01/2019
1	Pathologic Processes 09/2016
1	Necrosis 10/2014
1	Pigmented Nevus (Melanocytic Nevus) 10/2014
1	Ganglioglioma 02/2014
1	Glioblastoma (Glioblastoma Multiforme) 02/2014
1	Ependymoma 02/2014
1	Oligodendroglioma 02/2014
1	Astrocytoma (Pilocytic Astrocytoma) 02/2014
1	Glioma (Gliomas) 02/2014
1	Breast Neoplasms (Breast Cancer) 01/2014
1	Lung Neoplasms (Lung Cancer) 09/2013
1	Colorectal Neoplasms (Colorectal Cancer) 06/2013
1	Pharyngeal Neoplasms 09/2012
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2012
1	Seminoma 01/2012
1	Nasal Polyps (Nasal Polyp) 03/2010
1	Asthma (Bronchial Asthma) 01/2009

Drug/Important Bio-Agent (IBA)

7	Vitamin D FDA LinkGeneric 11/2020 - 03/2013
7	25-Hydroxyvitamin D3 1-alpha-Hydroxylase (25 Hydroxyvitamin D3 1 alpha Hydroxylase)IBA 01/2019 - 03/2013
4	Melanins (Melanin)IBA 01/2019 - 03/2013
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 06/2013
3	Tretinoin (Retinoic Acid)FDA LinkGeneric 11/2020 - 09/2016
3	Vitamin D3 24-HydroxylaseIBA 01/2019 - 10/2014
3	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2019 - 10/2014
2	Messenger RNA (mRNA)IBA 01/2022 - 01/2014
2	Indicators and Reagents (Reagents)IBA 03/2016 - 02/2015
2	diazonaphthalenedisulfonic acid (NDS)IBA 02/2016 - 10/2015
2	Biomarkers (Surrogate Marker)IBA 06/2014 - 06/2013
2	Proteins (Proteins, Gene)FDA Link 01/2014 - 09/2012
2	ErbB Receptors (EGF Receptor)IBA 09/2013 - 06/2013
2	AntigensIBA 09/2012 - 03/2010
1	Nucleic AcidsIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2019
1	Mixed Function Oxygenases (Monooxygenases)IBA 01/2019
1	RetinoidsIBA 01/2019
1	CalciumIBA 01/2017
1	hydroxide ionIBA 01/2017
1	Calcitriol (Calcijex)FDA LinkGeneric 02/2015
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 02/2014
1	O(6)-Methylguanine-DNA MethyltransferaseIBA 02/2014
1	Mutant Proteins (Protein, Mutant)IBA 02/2014
1	CytokinesIBA 01/2014
1	Interleukin-4 (Interleukin 4)IBA 01/2014
1	InterferonsIBA 01/2014
1	Interleukin-6 (Interleukin 6)IBA 01/2014
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 09/2013
1	Gefitinib (Iressa)FDA Link 09/2013
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 09/2013
1	Panitumumab (Vectibix)FDA Link 06/2013
1	Cetuximab (Erbitux)FDA Link 06/2013
1	Codon (Codons)IBA 06/2013
1	EnzymesIBA 03/2013
1	Interleukin-2 Receptor alpha SubunitIBA 09/2012
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2012
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2012
1	Membrane Proteins (Integral Membrane Proteins)IBA 03/2010
1	MetallothioneinIBA 03/2010
1	SmokeIBA 01/2009

Therapy/Procedure

6	Therapeutics 01/2017 - 10/2013
3	Radiotherapy 04/2016 - 01/2012
3	Drug Therapy (Chemotherapy) 04/2016 - 01/2012
1	Immunotherapy 02/2016
1	Cystectomy 09/2014
1	Operative Surgical Procedures 09/2013